Posted On: 01/13/2015 10:39:22 PM
Post# of 129
Exact Sciences Names Scott Coward as General Counsel
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Scott Coward has been named Senior Vice President and General Counsel for the company effective January 1, 2015.
"Scott is a talented lawyer whose extensive legal and healthcare industry expertise makes him a perfect fit for our rapidly growing business," said Kevin Conroy, president, CEO and chairman of Exact Sciences. "His passion for healthcare innovation will fit seamlessly into our culture. He will be an important asset to our leadership team as we continue to work to broaden patient and provider access to Cologuard, the first FDA-approved noninvasive stool DNA colorectal cancer screening test, as well as develop new cancer screening technologies."....
http://investor.exactsciences.com/releasedeta...eID=890547
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Scott Coward has been named Senior Vice President and General Counsel for the company effective January 1, 2015.
"Scott is a talented lawyer whose extensive legal and healthcare industry expertise makes him a perfect fit for our rapidly growing business," said Kevin Conroy, president, CEO and chairman of Exact Sciences. "His passion for healthcare innovation will fit seamlessly into our culture. He will be an important asset to our leadership team as we continue to work to broaden patient and provider access to Cologuard, the first FDA-approved noninvasive stool DNA colorectal cancer screening test, as well as develop new cancer screening technologies."....
http://investor.exactsciences.com/releasedeta...eID=890547
(0)
(0)
